HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife Nutrition Ltd.

https://www.herbalife.com/

Latest From Herbalife Nutrition Ltd.

Herbalife's 10.3% Slump Tracks With Full-Year Guidance But Light Seen At The End Of 2022

Herbalife reported a double digit decrease in net sales during its second quarter, following similar results in the first quarter. The direct seller also plans to launch its digital platform Herbalife One to connect distributers and consumers and promote sales.

Sales & Earnings Dietary Supplements

USANA’s Preliminary Earnings Alert Could Signal Trend In Q2 Results Across Consumer Health

Pandemic-related market lockdowns, shipping backlogs and other disruptions in mainland China and other countries USANA referenced in announcement also could affect results for its direct-selling competitors as well as other firms in health, wellness, personal care and beauty industries.

Consumer Supply Chain

HBW US Market News: FTC Returns 'Free Trial' Losses, Old Spice Targets 'Meat Sweats,' More

FTC returns more than $5.4m to more than 100,000 consumers from "free trial" scam;" Hood College names Nutrition Science Program's founding director; Cremer introduces gummy-counting machine; Herbalife renovates LA headquarters; Arby's and Old Spice team up to fight "meat sweats."

Ad Campaigns Consumer

US Q1 Consumer Health Earnings Preview: Pivoting From Planning Changes To Parsing Results

Inflation's impact on consumer spending will be front and center in sector’s quarterly reports, beginning with J&J on 19 April. Potential impact also from price hikes common from most firms since early 2021 in response to increasing costs. Russia’s invasion of Ukraine also will prompt comment.

Consumer Sales & Earnings
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register